Financials
Income statement
Fiscal date | Mar 2025 | Mar 2024 | Sep 2023 | Dec 2022 |
---|---|---|---|---|
Total reported revenue | — | — | 89.9B | 91.0B |
Cost of revenue | — | — | 24.9B | 31.8B |
Gross profit | — | — | 65.0B | 59.2B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | 73.6B | -62.8B |
Other operating expenses | — | — | — | — |
Operating income | — | — | -406M | 11.3B |
Non operating interest income | ||||
Income | — | — | 562M | 499M |
Expense | — | — | 445M | 287M |
Other income expense | — | — | — | — |
Pretax income | — | — | 6.1B | 1.3B |
Tax provision | — | — | 1.2B | 172M |
Net income | — | — | 4.9B | 1.1B |
Basic EPS | 0.2 | 0.2 | — | — |
Diluted EPS | 0.2 | 0.2 | — | — |
Basic average shares | 28.2B | 28.2B | — | — |
Diluted average shares | 28.2B | 28.2B | — | — |
EBITDA | — | — | 27.5B | 24.7B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | -22M | -37M |
Preferred stock dividends | — | — | 0 | 0 |